ConductScience.org, home

Library / Genes

SUZ12: SUZ12 polycomb repressive complex 2 subunit

1 protein, 19 patents, 0 drugs, 0 trials, 3,157 NIH grants and 4,728 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolSUZ12HGNC
NameSUZ12 polycomb repressive complex 2 subunitHGNC
NCBI Gene ID23512NCBI Gene
HGNC IDHGNC:17101HGNC
EnsemblENSG00000178691NCBI Gene
AliasesCHET9, IMMAS, JJAZ1, KIAA0160NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q15022Polycomb protein SUZ1273933Ensembl, GeneID, HGNCUniProt

Patents 19

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4641201 A22025-10-294654Q15022Espacenet
JP 2025517969 A2025-06-124654Q15022Espacenet
US 11446398 B22022-09-2085332Q15022Espacenet
JP 2022524081 A2022-04-27188303Q15022Espacenet
US 11078247 B22021-08-0311205Q15022Espacenet
US 11047010 B22021-06-292785Q15022Espacenet
US 10865447 B22020-12-152785Q15022Espacenet
JP 2019527037 A2019-09-2637Q15022Espacenet
JP 2019033757 A2019-03-0724608Q15022Espacenet
US 9907842 B22018-03-06154Q15022Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3157

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant842,025NIH's project files
P30CA016672Cancer Center Support Grant362,025NIH's project files
P30CA016087Cancer Center Support Grant162,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)152,025NIH's project files
P30CA006973Regional Oncology Research Center132,025NIH's project files
P30CA016058Cancer Center Support Grant122,025NIH's project files
P30CA016086Cancer Center Support Grant112,025NIH's project files
R01CA097098Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer112,025NIH's project files
P30CA060553The Robert H. Lurie Comprehensive Cancer Center102,025NIH's project files
P30CA023168Cancer Center Support Grant92,025NIH's project files

Papers 4728

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42759702PubTator, text miningPubMed
42749126PubTator, text miningPubMed
42723774PubTator, text miningPubMed
42658353PubTator, text miningPubMed
42595994PubTator, text miningPubMed
42595535PubTator, text miningPubMed
42582074PubTator, text miningPubMed
42523552PubTator, text miningPubMed
42512967PubTator, text miningPubMed
42326014PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license